Men’s Health

Robot-assisted surgery represents safe, effective option for patients with kidney, bladder, prostate cancers

June 11, 2008

UT Health Science Center, CHRISTUS Santa Rosa Health Care have removedmore kidney, bladder tumors with the technology than any academic center in Texas.

Read more

Prostate cancer research study compares standard treatment to controversial watchful waiting option

February 8, 2008

With an estimated 1 in 6 American men being diagnosed with prostate cancer at some point in their lives and only 1 in 35 estimated to die of the disease*, some researchers are questioning how many of those men are receiving treatment and impairing their quality of life unnecessarily.

Read more

Study: Age adjustment may be delaying detection of prostate cancers in senior men

September 21, 2007

Age adjustment, a method used by physicians to evaluate prostate-specific antigen (PSA) levels and cancer risk in men according to age, may be hindering the early detection of prostate cancer in older men, according to a study released Sept. 14 in the Journal of Urology.

Read more

Study: Cork tree extract reduces prostate cancer in mice

May 16, 2007

A natural, over-the-counter herbal supplement on the market to help joint inflammation also shows robust ability to curb prostate cancer, according to a rodent study described by researchers from The University of Texas Health Science Center at San Antonio.

Read more

Finasteride boosts PSA ability to detect prostate cancer

August 22, 2006

The medication finasteride, which after the seven-year Prostate Cancer Prevention Trial (PCPT) was associated with a 24.8 percent reduction of prostate cancer risk among men who took it, has a new feather in its cap – it beefs up the diagnostic power of the prostate-specific antigen (PSA) test.

Read more

Cork tree extract puts a cork on prostate cancer growth, study shows

August 8, 2006

An over-the counter herbal supplement derived from the Amur cork tree (Phellodendron amurense) killed a high percentage of cultured prostate cancer cells in studies conducted at The University of Texas Health Science Center at San Antonio.

Read more